The role of TMP21 in trafficking and Amyloid-β precursor protein (APP) processing in Alzheimer's disease

Current Alzheimer Research

Volumn 9, Issue 4, 2012, Pages 411-424

  Bromley Brits, Kelley ^a   Song, Weihong ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Alzheimer; TM21; Trafficking

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BRAIN PROTEIN; BREFELDIN A; COAT PROTEIN COMPLEX I; COATOMER PROTEIN; GAMMA SECRETASE; MONENSIN; NICASTRIN; PROTEIN TMP21; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; ENZYME ACTIVITY; ENZYME REGULATION; GOLGI COMPLEX; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

EID: 84860532440     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720512800492521     Document Type: Article

References (231)

1. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890 (1984).
2. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubuleassociated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83: 4913-4917 (1986).
3. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261: 6084-6089 (1986).
4. Kosik KS, Joachim CL, Selkoe DJ. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA 83: 4044-4048 (1986).
5. Wood JG, Mirra SS, Pollock NJ, Binder LI. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc Natl Acad Sci USA 83: 4040-4043 (1986).
6. Li Y, Zhou W, Tong Y, He G, Song W. Control of APP processing and Abeta generation level by BACE1 enzymatic activity and transcription. FASEB J 20: 285-292 (2006).
7. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, et al. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248:1122-1124 (1990).
8. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492-495 (1990).
9. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736 (1987).
10. Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331: 525-527 (1988).
11. Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve RL. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331: 528-530 (1988).
12. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331: 530-532 (1988).
13. Dyrks T, Weidemann A, Multhaup G, Salbaum JM, Lemaire HG, Kang J, et al. Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. Embo J 7: 949-957 (1988).
14. Weidemann A, Kuig G, Bunke D, Fischer P, Salbaum JM, Masters CL, et al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57: 115-126 (1989).
15. Buxbaum JD, Gandy SE, Cicchetti P, Ehrlich ME, Czernik AJ, Fracasso RP, et al. Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci USA 87: 6003-6006 (1990).
16. Gandy S, Czernik AJ, Greengard P. Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulin-dependent protein kinase II. Proc Natl Acad Sci USA 85: 6218-6221 (1988).
17. Koo EH, Squazzo SL. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269:17386-17389 (1994).
18. Koo EH, Squazzo SL, Selkoe DJ, Koo CH. Trafficking of cell-surface amyloid beta-protein precursor. I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody. J Cell Sci 109 (Pt 5): 991-998 (1996).
19. Caporaso GL, Gandy SE, Buxbaum JD, Greengard P. Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci USA 89: 2252-2256 (1992).
20. Oltersdorf T, Ward PJ, Henriksson T, Beattie EC, Neve R, Lieberburg I, et al. The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J Biol Chem 265: 4492-4497 (1990).
21. Selkoe DJ, Podlisny MB, Joachim CL, Vickers EA, Lee G, Fritz LC, et al. Beta-amyloid precursor protein of Alzheimer disease occurs as 110to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci USA 85: 7341-7345 (1988).
22. Caporaso GL, Gandy SE, Buxbaum JD, Ramabhadran TV, Greengard P. Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci USA 89: 3055-3059 (1992)
23. Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255: 728-730 (1992).
24. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357: 500-503 (1992).
25. Nordstedt C, Caporaso GL, Thyberg J, Gandy SE, Greengard P. Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells. J Biol Chem 268: 608-612 (1993).
26. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, et al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402: 533-537 (1999).
27. Hussain I, Powell DJ, Howlett DR, Chapman GA, Gilmour L, Murdock PR, et al. ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site. Mol Cell Neurosci 16: 609-619 (2000).
28. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, et al. Purification and cloning of amyloid precursor protein betasecretase from human brain. Nature 402: 537-540 (1999).
29. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741 (1999).
30. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, et al. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 4: 233-234 (2001).
31. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, et al. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci 4: 231-232 (2001).
32. Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, et al. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet 10:1317-1324 (2001).
33. Sun X, He G, Song W. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome. FASEB J 20: 1369-1376 (2006).
34. Sun X, Wang Y, Qing H, Christensen MA, Liu Y, Zhou W, et al. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes. FASEB J 19: 739-749 (2005).
35. Acquati F, Accarino M, Nucci C, Fumagalli P, Jovine L, Ottolenghi S, et al. The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Lett 468: 59-64 (2000).
36. Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci USA 97: 1456-1460 (2000).
37. Bennett BD, Denis P, Haniu M, Teplow DB, Kahn S, Louis JC, et al. A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's betasecretase. J Biol Chem 275: 37712-37717 (2000).
38. Lahiri DK, Maloney B, Ge YW. Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal cells. J Mol Neurosci 29: 65-80 (2006).
39. Basi G, Frigon N, Barbour R, Doan T, Gordon G, McConlogue L, et al. Antagonistic effects of beta-site amyloid precursor proteincleaving enzymes 1 and 2 on beta-amyloid peptide production in cells. J Biol Chem 278: 31512-31520 (2003).
40. Sun X, He G, Song W. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome. FASEB J 20: 1369-1376 (2006).
41. Sun X, Bromley-Brits K Song Regulation of beta-site APPcleaving enzyme 1 (BACE1) gene expression and its role in Alzheimer's Disease. Journal of Neurochemistry in press.
42. Christensen MA, Zhou W, Qing H, Lehman A, Philipsen S, Song W. Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. Mol Cell Biol 24: 865-874 (2004).
43. Tong Y, Zhou W, Fung V, Christensen MA, Qing H, Sun X, Song W. Oxidative stress potentiates BACE1 gene expression and Abeta generation. J Neural Transm 112: 455-469 (2005).
44. Zhou W, Song W. Leaky scanning and reinitiation regulate BACE1 gene expression. Mol Cell Biol 26: 3353-3364 (2006).
45. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82: 4245-4249 (1985).
46. Näslund J, Schierhorn A, Hellman U, Lannfelt L, Roses AD, Tjernberg LO, et al. Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci USA 91: 8378-8382 (1994).
47. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360: 672-674 (1992).
48. Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W, Selkoe DJ, et al. Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J Biol Chem 274: 18851-18856 (1999).
49. Perez RG, Squazzo SL, Koo EH. Enhanced release of amyloid beta-protein from codon 670/671 Swedish mutant beta-amyloid precursor protein occurs in both secretory and endocytic pathways. J Biol Chem 271: 9100-9107 (1996).
50. Wertkin AM, Turner RS, Pleasure SJ, Golde TE, Younkin SG, Trojanowski JQ, et al. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. Proc Natl Acad Sci USA 90: 9513-9517 (1993).
51. Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ. beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268: 3021-3024 (1993).
52. Martin BL, Schrader-Fischer G, Busciglio J, Duke M, Paganetti P, Yankner BA. Intracellular accumulation of beta-amyloid in cells expressing the Swedish mutant amyloid precursor protein. J Biol Chem 270: 26727-26730 (1995).
53. Tartakoff AM. Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell 32: 1026-1028 (1983).
54. Stephens DJ, Austen BM. Metabolites of the beta-amyloid precursor protein generated by beta-secretase localise to the transGolgi network and late endosome in 293 cells. J Neurosci Res 46: 211-225 (1996).
55. Kopan R, Schroeter EH, Weintraub H, Nye JS. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci USA 93:1683-1688 (1996).
56. Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393: 382-386 (1998).
57. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89: 629-639 (1997).
58. Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ, Trumbauer ME, et al. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387: 288-292 (1997).
59. Donoviel DB, Hadjantonakis AK, Ikeda M, Zheng H, Hyslop PS, Bernstein A. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev 13: 2801-2810 (1999).
60. Song W, Nadeau P, Yuan M, Yang X, Shen J, Yankner BA. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proc Natl Acad Sci USA 96: 6959-6963 (1999).
61. Strooper BD, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, et al: A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398: 518-522 (1999).
62. George-Hyslop PS, Haines J, Rogaev E, Mortilla M, Vaula G, Pericak-Vance M, et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 2: 330-334 (1992).
63. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269: 973-977 (1995).
64. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, Weber JL, et al. A familial Alzheimer's disease locus on chromosome 1. Science 269: 970-973 (1995).
65. Li J, Ma J, Potter H. Identification and expression analysis of a potential familial Alzheimer disease gene on chromosome 1 related to AD3. Proc Natl Acad Sci USA 92:12180-12184 (1995).
66. Mullan M, Houlden H, Windelspecht M, Fidani L, Lombardi C, Diaz P, et al. A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1antichymotrypsin gene. Nat Genet 2: 340-342 (1992).
67. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 775-778 (1995).
68. Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258: 668-671 (1992).
69. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760 (1995).
70. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19: 939-945 (1997).
71. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17: 1005-1013(1996).
72. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2: 864-870 (1996).
73. Naruse S, Thinakaran G, Luo JJ, Kusiak JW, Tomita T, Iwatsubo T, et al. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21: 1213-1221 (1998).
74. Strooper BD, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391: 387-390 (1998).
75. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398: 513-517 (1999).
76. Steiner H, Duff K, Capell A, Romig H, Grim MG, Lincoln S, et al. A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling. J Biol Chem 274: 28669-28673 (1999).
77. Esler WP, Kimberly WT, Ostaszewski BL, Diehl TS, Moore CL, Tsai JY, et al. Transition-state analogue inhibitors of gammasecretase bind directly to presenilin-1. Nat Cell Biol 2: 428-434 (2000).
78. Li YM, Lai MT, Xu M, Huang Q, DiMuzio-Mower J, Sardana MK, et al. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA 97: 6138-6143 (2000).
79. Li YM, Xu M, Lai MT, Huang Q, Castro JL, DiMuzio-Mower J, et al. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405: 689-694 (2000).
80. Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, Strooper BD. Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat Cell Biol 2: 461-462 (2000).
81. Zhang Z, Nadeau P, Song W, Donoviel D, Yuan M, Bernstein A, et al. Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1. Nat Cell Biol 2: 463-465 (2000).
82. Petit A, Bihel F, da Costa CA, Pourqui O, Checler F, Kraus JL. New protease inhibitors prevent gamma-secretase-mediated production of Abeta40/42 without affecting Notch cleavage. Nat Cell Biol 3: 507-511 (2001).
83. Chen F, Gu Y, Hasegawa H, Ruan X, Arawaka S, Fraser P, et al. Presenilin 1 mutations activate gamma 42-secretase but reciprocally inhibit epsilon-secretase cleavage of amyloid precursor protein (APP) and S3-cleavage of notch. J Biol Chem 277: 36521-36526 (2002).
84. Ratovitski T, Slunt HH, Thinakaran G, Price DL, Sisodia SS, Borchelt DR. Endoproteolytic processing and stabilization of wildtype and mutant presenilin. J Biol Chem 272: 24536-24541 (1997).
85. Thinakaran G, Harris CL, Ratovitski T, Davenport F, Slunt HH, Price DL, et al. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J Biol Chem 272: 28415-28422 (1997).
86. Thinakaran G, Teplow DB, Siman R, Greenberg B, Sisodia SS. Metabolism of the Swedish amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the beta-secretase site occurs in the golgi apparatus. J Biol Chem 271: 9390-9397 (1996).
87. Kim TW, Pettingell WH, Hallmark OG, Moir RD, Wasco W, Tanzi RE. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J Biol Chem 272: 11006-11010 (1997).
88. Kovacs DM, Fausett HJ, Page KJ, Kim TW, Moir RD, Merriam DE, et al. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med 2: 224-229(1996).
89. Capell A, Grberg J, Pesold B, Diehlmann A, Citron M, Nixon R, et al. The proteolytic fragments of the Alzheimer's diseaseassociated presenilin-1 form heterodimers and occur as a 100-150kDa molecular mass complex. J Biol Chem 273: 3205-3211 (1998).
90. Seeger M, Nordstedt C, Petanceska S, Kovacs DM, Gouras GK, Hahne S, et al. Evidence for phosphorylation and oligomeric assembly of presenilin 1. Proc Natl Acad Sci USA 94: 5090-5094 (1997).
91. Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 407: 48-54 (2000).
92. Chung HM, Struhl G. Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila. Nat Cell Biol 3: 1129-1132 (2001).
93. Hu Y, Ye Y, Fortini ME. Nicastrin is required for gamma-secretase cleavage of the Drosophila Notch receptor. Dev Cell 2: 69-78 (2002).
94. López-Schier H, Johnston DS. Drosophila nicastrin is essential for the intramembranous cleavage of notch. Dev Cell 2:79-89 (2002).
95. Esler WP, Kimberly WT, Ostaszewski BL, Ye W, Diehl TS, Selkoe DJ, et al. Activity-dependent isolation of the presenilingamma -secretase complex reveals nicastrin and a gamma substrate. Proc Natl Acad Sci USA 99: 2720-2725 (2002).
96. Kimberly WT, LaVoie MJ, Ostaszewski BL, Ye W, Wolfe MS, Selkoe DJ. Complex N-linked glycosylated nicastrin associates with active gamma-secretase and undergoes tight cellular regulation. J Biol Chem 277: 35113-35117 (2002).
97. Edbauer D, Winkler E, Haass C, Steiner H. Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. Proc Natl Acad Sci USA 99: 8666-8671 (2002).
98. Leem JY, Vijayan S, Han P, Cai D, Machura M, Lopes KO, et al. Presenilin 1 is required for maturation and cell surface accumulation of nicastrin. J Biol Chem 277: 19236-19240 (2002).
99. Yang D-S, Tandon A, Chen F, Yu G, Yu H, Arawaka S, et al. Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins. J Biol Chem 277: 28135-28142 (2002).
100. Goutte C, Tsunozaki M, Hale VA, Priess JR. APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc Natl Acad Sci USA 9: 775-779 (2002).
101. Francis R, McGrath G, Zhang J, Ruddy DA, Sym M, Apfeld J, et al. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cell 3: 85-97 (2002).
102. jie Luo W, Wang H, Li H, Kim BS, Shah S, Lee H-J, et al. PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1. J Biol Chem 278:7850-7854 (2003).
103. Kim S-H, Ikeuchi T, Yu C, Sisodia SS. Regulated hyperaccumulation of presenilin-1 and the gamma-secretase complex. Evidence for differential intramembranous processing of transmembrane subatrates. J Biol Chem 278: 33992-34002 (2003).
104. Takasugi N, Tomita T, Hayashi I, Tsuruoka M, Niimura M, Takahashi Y, et al. The role of presenilin cofactors in the gammasecretase complex. Nature 422: 438-441 (2003).
105. Shah S, Lee S-F, Tabuchi K, Hao Y-H, Yu C, LaPlant Q, et al. Nicastrin functions as a gamma-secretase-substrate receptor. Cell 122: 435-447 (2005).
106. Kimberly WT, LaVoie MJ, Ostaszewski BL, Ye W, Wolfe MS, Selkoe DJ. Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc Natl Acad Sci USA 100: 6382-6387 (2003).
107. Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, Haass C: Reconstitution of gamma-secretase activity. Nat Cell Biol 5: 486-488 (2003).
108. Steiner H, Winkler E, Edbauer D, Prokop S, Basset G, Yamasaki A, et al. PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin. J Biol Chem 277: 39062-39065 (2002).
109. Verdile G, Gandy SE, Martins RN. The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid. Neurochemical research 32: 609-623 (2007).
110. Zhou S, Zhou H, Walian PJ, Jap BK. CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production. Proc Natl Acad Sci USA 102:7499-7504 (2005).
111. Vetrivel KS, Zhang X, Meckler X, Cheng H, Lee S, Gong P, et al. Evidence that CD147 modulation of beta-amyloid (Abeta) levels is mediated by extracellular degradation of secreted Abeta. J Biol Chem 283:19489-19498 (2008).
112. He G, Luo W, Li P, Remmers C, Netzer WJ, Hendrick J, et al. Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease. Nature 467: 95-98 (2010).
113. Chen F, Hasegawa H, Schmitt-Ulms G, Kawarai T, Bohm C, Katayama T, et al. TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity. Nature 440:1208-1212 (2006).
114. Liu S, Bromley-Brits K, Xia K, Mittelholtz J, Wang R, Song W. TMP21 degradation is mediated by the ubiquitin-proteasome pathway. Eur J Neurosci 28:1980-1988 (2008).
115. Honda T, Yasutake K, Nihonmatsu N, Mercken M, Takahashi H, Murayama O, et al. Dual roles of proteasome in the metabolism of presenilin 1. J Neurochem 72: 255-261 (1999).
116. Steiner H, Capell A, Pesold B, Citron M, Kloetzel PM, Selkoe DJ, et al. Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. J Biol Chem 273: 32322-32331 (1998).
117. Fraser PE, Levesque G, Yu G, Mills LR, Thirlwell J, Frantseva M, et al. Presenilin 1 is actively degraded by the 26S proteasome. Neurobiol Aging 19: S19-S21 (1998).
118. He G, Qing H, Tong Y, Cai F, Ishiura S, Song W. Degradation of nicastrin involves both proteasome and lysosome. J Neurochem 101: 982-992 (2007).
119. Crystal AS, Morais VA, Fortna RR, Carlin D, Pierson TC, Wilson CA, et al. Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation. Biochemistry 43: 3555-3563 (2004).
120. Bergman A, Hansson EM, Pursglove SE, Farmery MR, Lannfelt L, Lendahl U, et al. Pen-2 is sequestered in the endoplasmic reticulum and subjected to ubiquitylation and proteasome-mediated degradation in the absence of presenilin. J Biol Chem 279: 16744-16753 (2004).
121. He G, Qing H, Cai F, Kwok C, Xu H, Yu G, et al. Ubiquitinproteasome pathway mediates degradation of APH-1. J Neurochem 99:1403-1412 (2006).
122. Keck S, Nitsch R, Grune T, Ullrich O. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J Neurochem 85:115-122 (2003).
123. David DC, Layfield R, Serpell L, Narain Y, Goedert M, Spillantini MG. Proteasomal degradation of tau protein. J Neurochem 83:176-185 (2002).
124. Nunan J, Shearman MS, Checler F, Cappai R, Evin G, Beyreuther K, et al. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase. Eur J Biochem 268: 5329-5336 (2001).
125. Qing H, Zhou W, Christensen MA, Sun X, Tong Y, Song W. Degradation of BACE by the ubiquitin-proteasome pathway. FASEB J 18:1571-1573 (2004).
126. Palade G: Intracellular aspects of the process of protein synthesis. Science 189: 347-358 (1975).
127. Beams HW, Kessel RG. The Golgi apparatus: structure and function. Int Rev Cytol 23: 209-276 (1968).
128. Bonfanti L, Mironov AA, Martez-Menguez JA, Martella O, Fusella A, et al. Procollagen traverses the Golgi stack without leaving the lumen of cisternae: evidence for cisternal maturation. Cell 95: 993-1003 (1998).
129. Farquhar MG. Progress in unraveling pathways of Golgi traffic. Annu Rev Cell Biol 1: 447-488 (1985).
130. Dunphy WG, Rothman JE. Compartmental organization of the Golgi stack. Cell 42:13-21 (1985).
131. Letourneur F, Gaynor EC, Hennecke S, Dollie C, Duden R, Emr SD, et al. Coatomer is essential for retrieval of dilysine-tagged proteins to the endoplasmic reticulum. Cell 79: 1199-1207 (1994).
132. Cosson P, Letourneur F. Coatomer interaction with di-lysine endoplasmic reticulum retention motifs. Science 263:1629-1631 (1994).
133. Lewis MJ, Pelham HR. Ligand-induced redistribution of a human KDEL receptor from the Golgi complex to the endoplasmic reticulum. Cell 68: 353-364 (1992).
134. Balch WE, Dunphy WG, Braell WA, Rothman JE. Reconstitution of the transport of protein between successive compartments of the Golgi measured by the coupled incorporation of Nacetylglucosamine. Cell 39: 405-416 (1984).
135. Orci L, Glick BS, Rothman JE. A new type of coated vesicular carrier that appears not to contain clathrin: its possible role in protein transport within the Golgi stack. Cell 46:171-184 (1986).
136. Melançon P, Glick BS, Malhotra V, Weidman PJ, Serafini T, Gleason ML, et al. Involvement of GTP-binding G proteins in transport through the Golgi stack. Cell 51: 1053-1062 (1987).
137. Donaldson JG, Cassel D, Kahn RA, Klausner RD. ADPribosylation factor, a small GTP-binding protein, is required for binding of the coatomer protein beta-COP to Golgi membranes. Proc Natl Acad Sci USA 89: 6408-6412 (1992).
138. Waters MG, Serafini T, Rothman JE. 'Coatomer': a cytosolic protein complex containing subunits of non-clathrin-coated Golgi transport vesicles. Nature 349: 248-251 (1991).
139. Serafini T, Orci L, Amherdt M, Brunner M, Kahn RA, Rothman JE. ADP-ribosylation factor is a subunit of the coat of Golgiderived COP-coated vesicles: a novel role for a GTP-binding protein. Cell 67: 239-253 (1991).
140. Orci L, Palmer DJ, Amherdt M, Rothman JE. Coated vesicle assembly in the Golgi requires only coatomer and ARF proteins from the cytosol. Nature 364:732-734 (1993).
141. Orci L, Palmer DJ, Ravazzola M, Perrelet A, Amherdt M, Rothman JE. Budding from Golgi membranes requires the coatomer complex of non-clathrin coat proteins. Nature 362: 648-652 (1993).
142. Karrenbauer A, Jeckel D, Just W, Birk R, Schmidt RR, Rothman JE, et al. The rate of bulk flow from the Golgi to the plasma membrane. Cell 63: 259-267 (1990).
143. Peter F, Plutner H, Zhu H, Kreis TE, Balch WE. Beta-COP is essential for transport of protein from the endoplasmic reticulum to the Golgi in vitro. J Cell Biol 122: 1155-1167 (1993).
144. Pepperkok R, Scheel J, Horstmann H, Hauri HP, Griffiths G, Kreis TE. Beta-COP is essential for biosynthetic membrane transport from the endoplasmic reticulum to the Golgi complex in vivo. Cell 74: 71-82 (1993).
145. Orci L, Stamnes M, Ravazzola M, Amherdt M, Perrelet A, Slner TH, et al. Bidirectional transport by distinct populations of COPIcoated vesicles. Cell 90: 335-349 (1997).
146. Fiedler K, Veit M, Stamnes MA, Rothman JE. Bimodal interaction of coatomer with the p24 family of putative cargo receptors. Science 273:1396-1399 (1996).
147. Orci L, Ravazzola M, Volchuk A, Engel T, Gmachl M, Amherdt M, et al. Anterograde flow of cargo across the golgi stack potentially mediated via bidirectional percolating COPI vesicles. Proc Natl Acad Sci USA 97: 10400-10405 (2000).
148. Schleifer LS, Kahn RA, Hanski E, Northup JK, Sternweis PC, Gilman AG. Requirements for cholera toxin-dependent ADPribosylation of the purified regulatory component of adenylate cyclase. J Biol Chem 257: 20-23 (1982).
149. Kahn RA, Gilman AG. Purification of a protein cofactor required for ADP-ribosylation of the stimulatory regulatory component of adenylate cyclase by cholera toxin. J Biol Chem 259: 6228-6234 (1984).
150. Kahn RA, Gilman AG. The protein cofactor necessary for ADPribosylation of Gs by cholera toxin is itself a GTP binding protein. J Biol Chem 261: 7906-7911 (1986).
151. Tsuchiya M, Price SR, Tsai SC, Moss J, Vaughan M. Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells. J Biol Chem 266: 2772-2777 (1991).
152. Traub LM, Ostrom JA, Kornfeld S. Biochemical dissection of AP-1 recruitment onto Golgi membranes. J Cell Biol 123: 561-573 (1993).
153. Stamnes MA, Rothman JE. The binding of AP-1 clathrin adaptor particles to Golgi membranes requires ADP-ribosylation factor, a small GTP-binding protein. Cell 73:999-1005 (1993).
154. Ooi CE, Dell'Angelica EC, Bonifacino JS. ADP-Ribosylation factor 1 (ARF1) regulates recruitment of the AP-3 adaptor complex to membranes. J Cell Biol 142: 391-402 (1998).
155. Helms JB, Rothman JE. Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature 360: 352-354 (1992).
156. Helms JB, Palmer DJ, Rothman JE. Two distinct populations of ARF bound to Golgi membranes. J Cell Biol 121: 751-760 (1993).
157. Franco M, Chardin P, Chabre M, Paris S. Myristoylation is not required for GTP-dependent binding of ADP-ribosylation factor ARF1 to phospholipids. J Biol Chem 268: 24531-24534 (1993).
158. Antonny B, Beraud-Dufour S, Chardin P, Chabre M. N-terminal hydrophobic residues of the G-protein ADP-ribosylation factor-1 insert into membrane phospholipids upon GDP to GTP exchange. Biochemistry 36: 4675-4684 (1997).
159. Serafini T, Stenbeck G, Brecht A, Lottspeich F, Orci L, Rothman JE, et al. A coat subunit of Golgi-derived non-clathrin-coated vesicles with homology to the clathrin-coated vesicle coat protein beta-adaptin. Nature 349: 215-220 (1991).
160. Duden R, Griffiths G, Frank R, Argos P, Kreis TE. Beta-COP, a 110 kd protein associated with non-clathrin-coated vesicles and the Golgi complex, shows homology to beta-adaptin. Cell 64: 649-665 (1991).
161. Stenbeck G, Harter C, Brecht A, Herrmann D, Lottspeich F, Orci L, et al. beta'-COP, a novel subunit of coatomer. Embo J 12: 2841-2845 (1993).
162. Harter C, Draken E, Lottspeich F, Wieland FT. Yeast coatomer contains a subunit homologous to mammalian beta'-COP. FEBS Lett 332: 71-73 (1993).
163. Hara-Kuge S, Kuge O, Orci L, Amherdt M, Ravazzola M, Wieland FT, et al. En bloc incorporation of coatomer subunits during the assembly of COP-coated vesicles. J Cell Biol 124: 883-892 (1994).
164. Kuge O, Hara-Kuge S, Orci L, Ravazzola M, Amherdt M, Tanigawa G, et al. zeta-COP, a subunit of coatomer, is required for COP-coated vesicle assembly. J Cell Biol 123: 1727-1734 (1993).
165. Blagitko N, Schulz U, Schinzel AA, Ropers HH, Kalscheuer VM. gamma2-COP, a novel imprinted gene on chromosome 7q32, defines a new imprinting cluster in the human genome. Hum Mol Genet 8: 2387-2396 (1999).
166. Futatsumori M, Kasai K, Takatsu H, Shin HW, Nakayama K. Identification and characterization of novel isoforms of COP I subunits. J Biochem 2000, 128:793-801.
167. Yamasaki K, Hayashida S, Miura K, Masuzaki H, Ishimaru T, Niikawa N, Kishino T: The novel gene, gamma2-COP (COPG2), in the 7q32 imprinted domain escapes genomic imprinting. Genomics 68: 330-335 (2000).
168. Wegmann D, Hess P, Baier C, Wieland FT, Reinhard C. Novel isotypic gamma/zeta subunits reveal three coatomer complexes in mammals. Mol Cell Biol 24: 1070-1080 (2004).
169. Donaldson JG, Finazzi D, Klausner RD. Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein. Nature 360: 350-352 (1992).
170. Palmer DJ, Helms JB, Beckers CJ, Orci L, Rothman JE. Binding of coatomer to Golgi membranes requires ADP-ribosylation factor. J Biol Chem 268:12083-12089 (1993).
171. Zhao L, Helms JB, Brger B, Harter C, Martoglio B, Graf R, et al. Direct and GTP-dependent interaction of ADP ribosylation factor 1 with coatomer subunit beta. Proc Natl Acad Sci USA 194:4418-4423 (1997).
172. Sun Z, Anderl F, Frolich K, Zhao L, Hanke S, Brer B, et al. Multiple and stepwise interactions between coatomer and ADPribosylation factor-1 (Arf1)-GTP. Traffic 8:582-593 (2007).
173. Zhao L, Helms JB, Brunner J, Wieland FT. GTP-dependent binding of ADP-ribosylation factor to coatomer in close proximity to the binding site for dilysine retrieval motifs and p23. J Biol Chem 274:14198-14203 (1999).
174. Eugster A, Frigerio G, Dale M, Duden R. COP I domains required for coatomer integrity, and novel interactions with ARF and ARFGAP. Embo J 19: 3905-3917 (2000).
175. Guo Q, Penman M, Trigatti BL, Krieger M. A single point mutation in epsilon-COP results in temperature-sensitive, lethal defects in membrane transport in a Chinese hamster ovary cell mutant. J Biol Chem 271: 11191-11196 (1996).
176. Guo Q, Vasile E, Krieger M. Disruptions in Golgi structure and membrane traffic in a conditional lethal mammalian cell mutant are corrected by epsilon-COP. J Cell Biol 125:1213-1224 (1994).
177. Ostermann J, Orci L, Tani K, Amherdt M, Ravazzola M, Elazar Z, et al. Stepwise assembly of functionally active transport vesicles. Cell 75:1015-1025 (1993).
178. Bremser M, Nickel W, Schweikert M, Ravazzola M, Amherdt M, Hughes CA, et al. Coupling of coat assembly and vesicle budding to packaging of putative cargo receptors. Cell 96: 495-506 (1999).
179. Jackson MR, Nilsson T, Peterson PA. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. Embo J 9: 3153-3162 (1990).
180. Nilsson T, Jackson M, Peterson PA. Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 58: 707-718 (1989).
181. Lowe M, Kreis TE. In vitro assembly and disassembly of coatomer. J Biol Chem 270: 31364-31371 (1995).
182. Sohn K, Orci L, Ravazzola M, Amherdt M, Bremser M, Lottspeich F, et al. A major transmembrane protein of Golgi-derived COPIcoated vesicles involved in coatomer binding. J Cell Biol 135:1239-1248 (1996).
183. Stamnes MA, Craighead MW, Hoe MH, Lampen N, Geromanos S, Tempst P, et al. An integral membrane component of coatomercoated transport vesicles defines a family of proteins involved in budding. Proc Natl Acad Sci USA 92: 8011-8015 (1995).
184. Dominguez M, Dejgaard K, Flekrug J, Dahan S, Fazel A, Paccaud JP, Thomas DY, Bergeron JJ, Nilsson T: gp25L/emp24/p24 protein family members of the cis-Golgi network bind both COP I and II coatomer. J Cell Biol 140: 751-765 (1998).
185. Harter C, Pavel J, Coccia F, Draken E, Wegehingel S, Tschochner H, et al. Nonclathrin coat protein gamma, a subunit of coatomer, binds to the cytoplasmic dilysine motif of membrane proteins of the early secretory pathway. Proc Natl Acad Sci USA 93: 1902-1906 (1996).
186. Harter C, Wieland FT. A single binding site for dilysine retrieval motifs and p23 within the gamma subunit of coatomer. Proc Natl Acad Sci USA 95: 11649-11654 (1998).
187. Gommel DU, Memon AR, Heiss A, Lottspeich F, Pfannstiel J, Lechner J, et al. Recruitment to Golgi membranes of ADPribosylation factor 1 is mediated by the cytoplasmic domain of p23. Embo J 20: 6751-6760 (2001).
188. Majoul I, Straub M, Hell SW, Duden R, Sing HD. KDEL-cargo regulates interactions between proteins involved in COPI vesicle traffic: measurements in living cells using FRET. Dev Cell 1: 139-153 (2001).
189. Fligge TA, Reinhard C, Harter C, Wieland FT, Przybylski M. Oligomerization of peptides analogous to the cytoplasmic domains of coatomer receptors revealed by mass spectrometry. Biochemistry 39: 8491-8496 (2000).
190. Fllekrug J, Suganuma T, Tang BL, Hong W, Storrie B, Nilsson T. Localization and recycling of gp27 (hp24gamma3): complex formation with other p24 family members. Mol Biol Cell 10:1939-1955 (1999).
191. Gommel D, Orci L, Emig EM, Hannah MJ, Ravazzola M, Nickel W, et al. p24 and p23, th e major transmembrane proteins of COPIcoated transport vesicles, form hetero-oligomeric complexes and cycle between the organelles of the early secretory pathway. FEBS Lett 447: 179-185 (1999).
192. Marzioch M, Henthorn DC, Herrmann JM, Wilson R, Thomas DY, Bergeron JJ, et al. Erp1p and Erp2p, partners for Emp24p and Erv25p in a yeast p24 complex. Mol Biol Cell 10: 1923-1938 (1999).
193. Reinhard C, Harter C, Bremser M, Bger B, Sohn K, Helms JB, et al. Receptor-induced polymerization of coatomer. Proc Natl Acad Sci USA 96: 1224-1228 (1999).
194. Weidler M, Reinhard C, Friedrich G, Wieland FT, Rch P. Structure of the cytoplasmic domain of p23 in solution: implications for the formation of COPI vesicles. Biochem Biophys Res Commun 271: 401-408 (2000).
195. Blum R, Feick P, Puype M, Vandekerckhove J, Klengel R, Nastainczyk W, et al. Tmp21 and p24A, two type I proteins enriched in pancreatic microsomal membranes, are members of a protein family involved in vesicular trafficking. J Biol Chem 271:17183-17189 (1996).
196. Blum R, Pfeiffer F, Feick P, Nastainczyk W, Kohler B, Schr KH, et al. Intracellular localization and in vivo trafficking of p24A and p23. J Cell Sci 112 (Pt 4): 537-548 (1999).
197. Rojo M, Pepperkok R, Emery G, Kellner R, Stang E, Parton RG, et al. Involvement of the transmembrane protein p23 in biosynthetic protein transport. J Cell Biol 139: 1119-1135 (1997).
198. Nickel W, Sohn K, Bning C, Wieland FT. p23, a major COPIvesicle membrane protein, constitutively cycles through the early secretory pathway. Proc Natl Acad Sci USA 94: 11393-11398 (1997).
199. Rojo M, Emery G, Marjomi V, McDowall AW, Parton RG, Gruenberg J. The transmembrane protein p23 contributes to the organization of the Golgi apparatus. J Cell Sci 113 (Pt 6): 1043-1057 (2000).
200. Springer S, Chen E, Duden R, Marzioch M, Rowley A, Hamamoto S, et al. The p24 proteins are not essential for vesicular transport in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 97: 4034-4039 (2000).
201. Denzel A, Otto F, Girod A, Pepperkok R, Watson R, Rosewell I, et al. The p24 family member p23 is required for early embryonic development. Curr Biol 10: 55-58 (2000).
202. Sollner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Geromanos S, Tempst P, et al. SNAP receptors implicated in vesicle targeting and fusion. Nature 362: 318-324 (1993).
203. Shorter J, Beard MB, Seemann J, Dirac-Svejstrup AB, Warren G. Sequential tethering of Golgins and catalysis of SNAREpin assembly by the vesicle-tethering protein p115. J Cell Biol 157: 45-62 (2002).
204. Nakamura N, Rabouille C, Watson R, Nilsson T, Hui N, Slusarewicz P, et al. Characterization of a cis-Golgi matrix protein, GM130. J Cell Biol 131:1715-1726 (1995).
205. Barroso M, Nelson DS, Sztul E. Transcytosis-associated protein (TAP)/p115 is a general fusion factor required for binding of vesicles to acceptor membranes. Proc Natl Acad Sci USA 92: 527-531 (1995).
206. Sztul E, Colombo M, Stahl P, Samanta R. Control of protein traffic between distinct plasma membrane domains. Requirement for a novel 108,000 protein in the fusion of transcytotic vesicles with the apical plasma membrane. J Biol Chem 268: 1876-1885 (1993).
207. Sztul E, Kaplin A, Saucan L, Palade G. Protein traffic between distinct plasma membrane domains: isolation and characterization of vesicular carriers involved in transcytosis. Cell 64: 81-89 (1991).
208. Waters MG, Clary DO, Rothman JE. A novel 115-kD peripheral membrane protein is required for intercisternal transport in the Golgi stack. J Cell Biol 118: 1015-1026 (1992).
209. Shorter J, Warren G. A role for the vesicle tethering protein, p115, in the post-mitotic stacking of reassembling Golgi cisternae in a cell-free system. J Cell Biol 146: 57-70 (1999).
210. Levitan D, Doyle TG, Brousseau D, Lee MK, Thinakaran G, Slunt HH, et al. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc Natl Acad Sci USA 93: 14940-14944 (1996).
211. Nakamura N, Yamazaki S, Sato K, Nakano A, Sakaguchi M, Mihara K. Identification of potential regulatory elements for the transport of Emp24p. Mol Biol Cell 9: 3493-3503 (1998).
212. Linstedt AD, Hauri HP. Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa. Mol Biol Cell 4: 679-693 (1993).
213. Sönnichsen B, Lowe M, Levine T, Jämsä E, Dirac-Svejstrup B, Warren G. A role for giantin in docking COPI vesicles to Golgi membranes. J Cell Biol 140: 1013-1021 (1998).
214. Barr FA, Nakamura N, Warren G. Mapping the interaction between GRASP65 and GM130, components of a protein complex involved in the stacking of Golgi cisternae. Embo J 17: 3258-3268 (1998).
215. Barr FA, Puype M, Vandekerckhove J, Warren G. GRASP65, a protein involved in the stacking of Golgi cisternae. Cell 91: 253-262 (1997).
216. Barr FA, Preisinger C, Kopajtich R, Kner R. Golgi matrix proteins interact with p24 cargo receptors and aid their efficient retention in the Golgi apparatus. J Cell Biol 155: 885-891 (2001).
217. Füllekrug J, Suganuma T, Tang BL, Hong W, Storrie B, Nilsson T. Localization and recycling of gp27 (hp24gamma3): complex formation with other p24 family members. Mol Biol Cell 10: 1939-1955 (1999).
218. Fraering PC, Ye W, Strub J-M, Dolios G, LaVoie MJ, Ostaszewski BL, et al. Purification and characterization of the human gammasecretase complex. Biochemistry 43: 9774-9789 (2004).
219. Vetrivel KS, Gong P, Bowen JW, Cheng H, Chen Y, Carter M, et al. Dual roles of the transmembrane protein p23/TMP21 in the modulation of amyloid precursor protein metabolism. Mol Neurodegener 2: 4 (2007).
220. Winkler E, Hobson S, Fukumori A, Dumpelfeld B, Luebbers T, Baumann K, et al. Purification, Pharmacological Modulation, and Biochemical Characterization of Interactors of Endogenous Human gamma-Secretase (dagger). Biochemistry 2009.
221. Teranishi Y, Hur J-Y, Welander H, Frberg J, Aoki M, Winblad B, et al. Affinity pulldown of gamma-secretase and associated proteins from human and rat brain. J Cell Mol Med (2009).
222. Réchards M, Xia W, Oorschot VMJ, Selkoe DJ, Klumperman J. Presenilin-1 exists in both pre-and post-Golgi compartments and recycles via COPI-coated membranes. Traffic 4: 553-565 (2003).
223. Kaether C, Lammich S, Edbauer D, Ertl M, Rietdorf J, Capell A, Steiner H, Haass C. Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane. J Cell Biol 158: 551-561 (2002).
224. Yu G, Chen F, Nishimura M, Steiner H, Tandon A, Kawarai T, et al. Mutation of conserved aspartates affects maturation of both aspartate mutant and endogenous presenilin 1 and presenilin 2 complexes. J Biol Chem 275: 27348-27353 (2000).
225. Lefranc-Jullien S, Sunyach C, Checler F. APPepsilon, the epsilonsecretase-derived N-terminal product of the beta-amyloid precursor protein, behaves as a type I protein and undergoes alpha-, beta-, and gamma-secretase cleavages. J Neurochem 97: 807-817 (2006).
226. Pardossi-Piquard R, Bm C, Chen F, Kanemoto S, Checler F, Schmitt-Ulms G, et al.TMP21 transmembrane domain regulates gamma-secretase cleavage. J Biol Chem 284: 28634-28641 (2009).
227. Hasegawa H, Liu L, Nishimura M. Dilysine retrieval signalcontaining p24 proteins collaborate in inhibiting gamma-cleavage of amyloid precursor protein. J Neurochem 2010.
228. Vetrivel KS, Kodam A, Gong P, Chen Y, Parent AT, Kar S, et al. Localization and regional distribution of p23/TMP21 in the brain. Neurobiol Dis 2008.
229. Liu S, Zhang S, Bromley-Brits K, Cai F, Zhou W, Xia K, et al. Transcriptional Regulation of TMP21 by NFAT. Molecular Neurodegeneration 6: 21 (2011).
230. Abdul HM, Sama MA, Furman JL, Mathis DM, Beckett TL, Weidner AM, et al. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci 29: 12957-12969 (2009).
231. Pardossi-Piquard R, Böhm C, Chen F, Kanemoto S, Checler F, Schmitt-Ulms G, et al. TMP21 transmembrane domain regulates gamma-secretase cleavage. J Biol Chem 284: 28634-28641 (2009).